Innov Clin Neurosci. 2025;22(10–12):14–23. by Samaneh Ghorbani Shirkouhi, MSc; Seyed Sepehr Khatami, MD; Zohair Niroomand, MD; Saeed Sadigh-Eteghad, PhD; Shahrokh Yousefzadeh-Chabok, MD; and Sasan Andalib, PhD Ms. Ghorbani Shirkouhi is
Innov Clin Neurosci. 2025;22(10–12):24–32. by Mark A. Colijn, MD, MSc, FRCPC, UCNS Dr. Colijn is with the Department of Psychiatry, Mathison Centre for Mental Health Research and Education, and Hotchkiss
Innov Clin Neurosci. 2025;22(10–12):33–51. by Franco Di Cesare, MD; Cristiana Di Carlo, MPhil; and Leonardo Di Cesare, MD All authors are with Leoben Research Aurora in San Vincenzo Valle Roveto
Innov Clin Neurosci. 2025;22(10–12):57–71. by Jayant Totlani, DO; Muhammad Arsalan Bashir, MBBS; Laurel Tay, BA; Ashley Ngor, BS; Alexander J. Steiner, PsyD; Drew Hirsch, BS; Lorena Contreras, MA; Sabrina Renteria,
Innov Clin Neurosci. 2025;22(10–12):52–56. by Alexandria Nasr, MD; Larrilyn Grant, MD; Jennifer Golida, BS; and Bailey Hangen, BS, MS All authors are affiliated with the Boonshoft School of Medicine at
Innov Clin Neurosci. 2025;22(10–12):72–77. by Anam Shahid, PhD; Alia Asmat, PhD; and Sunny Singh, MD Dr. Shahid and Dr. Singh are with the Nova Scotia Health Authority in Sydney, Nova
Innov Clin Neur. 2025;22(10–12):78–85. November 2–5, 2025 in Boston, Massachusetts. Artificial intelligence (AI)/machine-based learning Digital phenotyping with real-world data to identify candidates for anti-CGRP migraine treatment Presenters: Giorgio Pietro Biondetti;
Innov Clin Neurosci. 2025;22(10–12):86–87. by Justin Pope, JD Mr. Pope is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation
Due to the timely nature of this topic, we are providing an advanced release of this article, ahead of the October-December 2025 issue publication. This article is subject to changes
Dear Editor: Although poststroke psychosis is a reasonably well-established clinical phenomenon,1 few articles describing the development of psychotic symptoms on the background of a perinatal stroke history or other anoxic
Dear Editor: I read with interest the article by Allen et al1 about a 19-year-old male transgender patient who developed seizures after intentionally taking 2,000mg of fluoxetine. His medical history
Dear Editor: We thank the author for their thoughtful and insightful comments on our case report.1 We fully agree that fluoxetine has a known potential to trigger seizures, especially in
by Rahi Patel, MD; Amin Ashraf, BS; Nicholas Myers, BS; and Nita Bhatt, MD, MPH Dr. Patel is with Beth Israel Deaconess Medical Center at Harvard Medical School in Boston,
Innov Clin Neurosci. 2025;22(7–9):18–23. by Robert G. Bashuk, MD; Stephen L. Scranton, MD, FACP; Robert S. Allen, AuD, and Marco Cecchi, PhD Drs. Bashuk and Allen are with the Concussion
Innov Clin Neurosci. 2025;22(7–9):24–27. by Muqadas Fatima, MS, and Uzma Ilyas, PhD Ms. Fatima is serving as Lecturer at National University of Modern Languages (NUML) in Lahore, Pakistan. Dr. Ilyas
Innov Clin Neurosci. 2025;22(7–9):32–39. by Ray M. Merrill, PhD, MPH Dr. Merrill is with the Department of Public Health in the College of Life Sciences at Brigham Young University in
Innov Clin Neurosci. 2025;22(7–9):40–41. by Adil Tumbi, MD; Amit Mistry, MD; BreAnna-Anh Le, BS; and Steven Lippmann, MD Drs. Tumbi and Mistry are with the Oklahoma City Veteran Affairs Health
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: We read with interest the article by Free et al1 about a 32-year-old female patient with a history of migraine, gastroesophageal reflux disease (GERD)
Helping Exceptionally Sensitive Patients See Their Sensitivity as a Gift
Innov Clin Neurosci. 2025;22(7–9):28–31. by Edmund G. Howe, MD, JD Dr. Howe is with Uniformed Services University of the Health Sciences in Bethesda, Maryland. FUNDING: No funding was provided for
Read More